Tonghua Dongbao Pharmaceutical Co., Ltd.

XSSC:600867 Stock Report

Market Cap: CN¥16.5b

Tonghua Dongbao Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Tonghua Dongbao Pharmaceutical has a total shareholder equity of CN¥6.4B and total debt of CN¥492.7M, which brings its debt-to-equity ratio to 7.7%. Its total assets and total liabilities are CN¥7.1B and CN¥693.9M respectively. Tonghua Dongbao Pharmaceutical's EBIT is CN¥558.2M making its interest coverage ratio -4.8. It has cash and short-term investments of CN¥372.8M.

Key information

7.7%

Debt to equity ratio

CN¥492.75m

Debt

Interest coverage ratio-4.8x
CashCN¥372.83m
EquityCN¥6.43b
Total liabilitiesCN¥693.87m
Total assetsCN¥7.12b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 600867's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥455.8M).

Long Term Liabilities: 600867's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥238.1M).


Debt to Equity History and Analysis

Debt Level: 600867's net debt to equity ratio (1.9%) is considered satisfactory.

Reducing Debt: 600867's debt to equity ratio has increased from 2.5% to 7.7% over the past 5 years.

Debt Coverage: 600867's debt is well covered by operating cash flow (124.5%).

Interest Coverage: 600867 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies